Using an SH-SY5Y culture model, ELAVL3 abnormalities appeared much earlier than TDP-43 abnormalities [67], suggesting ELAVL3 could have potential as a new biomarker for ALS or focus of therapeutic-targeted research. The gene discussed is ELAVL3; the disease is amyotrophic lateral sclerosis.